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Aceclofenac (AC) is a phenyl acetic acid derivative [2-(2’,6’-dichlorophenyl)amino]
phenylacetoxyacetic acid], a novel NSAID indicated for the symptomatic treatment of
pain and inflammation (1). The short biological half-life (about 4 h) and high frequency
of dosing make aceclofenac an ideal candidate for sustained release. The bioadhesive
microspheres of aceclofenac would prolong the residence time at the absorption site to
facilitate intimate contact with the absorption surface and thereby improve and enhance
bioavailability and increase patient compliance. Natural hydrophilic polymers like algi-
nate and pectin are widely used in numerous biomedical applications for their bioad-
hesion properties. Alginic acid and pectin are natural polysaccharides that are widely
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Ionotropic gelation was used to entrap aceclofenac into
algino-pectinate bioadhesive microspheres as a potential
drug carrier for the oral delivery of this anti-inflamma-
tory drug. Microspheres were investigated in vitro for
possible sustained drug release and their use in vivo as a
gastroprotective system for aceclofenac. Polymer concen-
tration and polymer/drug ratio were analyzed for their
influence on microsphere properties. The microspheres
exhibited good bioadhesive property and showed high
drug entrapment efficiency. Drug release profiles exhibi-
ted faster release of aceclofenac from alginate micros-
pheres whereas algino-pectinate microspheres showed
prolonged release. Dunnet’s multiple comparison analy-
sis suggested a significant difference in percent inhibi-
tion of paw edema when the optimized formulation was
compared to pure drug. It was concluded that the al-
gino-pectinate bioadhesive formulations exhibit promis-
ing properties of a sustained release form for aceclofenac
and that they provide distinct tissue protection in the
stomach.
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used as a vehicle for controlled drug delivery (2) due to their non-toxicity and low pro-
duction cost. In general, microspheres, have the potential to be used for targeted and
controlled-release drug delivery; but coupling of bioadhesive properties to microspheres
has additional advantages, e.g., efficient absorption, a much more intimate contact with
the mucus layer and specific targeting of the drug to the absorption site.
The objective of the present study was to design algino-pectinate bioadhesive mi-
crospheres of aceclofenac and evaluate the effect of polymer concentration on particle
size, encapsulation efficacy, enteric nature and drug release kinetics. The ionotropic gela-
tion technique was selected to prepare controlled release aceclofenac-loaded algino-pec-
tinate microspheres due to its simplicity, low cost and its high entrapment rates achie-
ved with poorly water-soluble drugs.
EXPERIMENTAL
Materials
Aceclofenac was a gift sample from Nicholas Primal India Ltd, India. Sodium algi-
nate (viscosity » 3.5 Pa s) was a gift from Signet Chemical Co, India. Pectin HM (high
methoxylated, Mr 1.758 ´ 106 Dalton) was a gift from CP Kelco, Denmark. Commercial
aceclofenac SR tablet 100 mg (MKT) was purchased from Aristo, India. All other chemi-
cals used were of analytical reagent grade.
Preparation of microspheres
Preparation of Na-alginate microspheres. – Na-alginate microspheres were prepared by
ionic cross-linking (Table I). Sodium alginate was dissolved in distilled water to obtain
different concentrations. Aceclofenac (5 %, m/m) was added to the sodium alginate solu-
tion and dispersed with an Ultraturrax (Jahnke and Kunkel, Germany) for 2 min at 8000
rpm. This dispersion was added dropvise to a calcium chloride solution (5 %, m/m) us-
ing a 24 G needle at a constant rate and under continuous stirring at 200 rpm. The stir-
ring was continued for 30 minutes, for complete reaction. After 30 minutes, microspheres
were collected by filtration, washed extensively with distilled water, and dried overnight
at room temperature.
Preparation of Na-alginate microspheres with pectin. – Pectin and Na-alginate solutions
of different concentrations (Table I) were separately prepared by dissolving both poly-
mers in water under gentle agitation. Pectin solution was then added into Na-alginate
solution and the mixture was stirred at 4000 rpm. Then, aceclofenac (5 %, m/m) was ad-
ded to the polymer solution and dispersed with an Ultraturrax for 2 min at 8000 rpm.
The remaining procedure was the same as for Na-alginate microspheres.
Evaluation of microspheres
Particle size. – Size and size distribution of microspheres were measured by sieve
analysis (3). The microspheres were separated into different size fractions (% mass frac-
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tion) by sieving for 5 min using standard sieves with nominal mesh apertures of 1.4, 1.2,
1.0, 0.85 and 0.71 mm and the particle size of the microspheres was determined (Table I).
Microencapsulation efficiency. – The drug content in microspheres was determined by
the reported method with a slight modification (4). The microspheres (100 mg) were
allowed to disintegrate in 50 mL of phosphate buffer (pH 6.8) for 4 h. Dispersion of mi-
crospheres was sonicated at 125 W for 30 min (Imeco Sonifier, Imeco Ultrasonics, India)
and the solution was filtered through a 0.45-mm filter. Then, the polymeric debris was
washed twice with fresh solvent (phosphate buffer) to extract any adhering drug. The
drug content of the filtrate was determined spectrophotometrically at 273 nm (UV-2450,
Shimadzu, Japan). Each determination was made in triplicate.
Micromeritic properties of microspheres. – The flow properties of microspheres were
studied by determining the angle of repose, Carr’s index (5), bulk density and tapped
density. The angle of repose was determined by the fixed-base cone method. Bulk and
tapped densities were determined using a digital bulk density apparatus (Electrolab, In-
dia). Each experiment was conducted in triplicate.
Enteric nature of microspheres. – The study was performed to observe whether the
drug released from the polymeric matrices in the acidic environment of the stomach. Fif-
ty milligrams of microspheres were soaked in 10 mL of 0.1 mol L–1 HCl at 37 ± 0.5 °C in
a water bath. After 2 hours, the sample was centrifuged (3000 rpm, 20 minutes). The su-
pernatant was subjected to UV-scan at 273 nm and analyzed for aceclofenac concentra-
tion against 0.1 mol L–1 HCl blank.
Scanning electron microscopy. – The sample was spread on a stub and coated for 120 s
with a layer of gold using a sputter coater and placed in the scanning electron micro-
scope (JSM 5610 LV SEM, JEOL, Japan) chamber at acceleration voltage of 20 kV, cham-
ber pressure of 0.6 mm Hg. Photographs were taken at different magnifications (Fig. 1).
Bioadhesive property of microspheres. – The bioadhesive property of the microspheres
was evaluated employing the method described by Lehr et al. (6). The test was perfor-
med in both simulated gastric fluid (0.1 mol L–1 HCl, pH 1.2) and simulated intestinal
fluid (phosphate buffer, pH 6.8). Freshly excised pieces of goat intestinal mucosa (2´3
cm) were mounted onto glass slides with cyanoacrylate glue. About 50 microspheres were
spread onto each wet rinsed tissue specimen and immediately thereafter the slides with
suitable support were hung onto the arm of a USP tablet disintegrating test machine.
The tissue specimen was given a slow, regular up-and-down movement in the test fluid
at 37 °C contained in a one liter vessel. At different time intervals (up to 8 h), the number
of microspheres still adhering to the tissue was counted.
FTIR. – The FTIR study was carried out using Prestige-21, Shimadzu, Japan. The pure
drug sample, pure polymers and formulations containing both drug and polymer were
scanned to study the possible drug and polymer interaction.
In vitro drug release study
Release of aceclofenac was determined using a USP six stage dissolution rate test
apparatus I (7) (Thermolab®, India) at 50 rpm. An accurately weighed aliquot of micro-
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particles equivalent to 100 mg of aceclofenac was added into each dissolution flask. Dis-
solution was studied using 900 mL of phosphate buffer (pH 6.8). The temperature was
maintained at 37 ± 0.2 °C. Samples of 5 mL each were withdrawn at different time inter-
vals, filtered through a Whatman filter membrane No. 1 (0.45 mm) (Auroco Pvt. Ltd,
Thailand) and replaced with an equal amount of fresh dissolution medium. Samples were
suitably diluted and analyzed for aceclofenac at 273 nm. The amount of aceclofenac was
calculated from the calibration curve. Release studies were conducted in triplicate.
Release profiles
The rate and mechanism of drug release from the prepared microspheres were ana-
lyzed by fitting the dissolution data into the zero-order equation:
Q = k0t
where Q is the amount of drug released at time t and k0 is the release rate constant, first-
-order equation:
ln(100 – Q) = ln100 – k1t
where k1 is the release rate constant, Higuchi’s equation (8):
Q = k2t1/2
where k2 is the diffusion rate constant.






where n is the release exponent indicative of the release mechanism, Mt/M is the frac-
tional release of the drug, t is the release time, k is the kinetic constant.
Preliminary anti-inflammatory activity study
The preclinical study (anti-inflammatory study) was carried out on male Wistar rats
(weighing 180–200 g) obtained from the Central Animal House, College of Pharmaceuti-
cal Sciences, Berhampur, India. They were housed in elevated wire cages, 4 animals per
cage, with free access to food (Lipton Feed, India) and water. The preclinical study pro-
tocol was approved by the Institutional Animal Ethical Committee, College of Pharma-
ceutical Sciences, Berhampur, India.
Carrageenean-induced rat paw edema model was used to assess the anti-inflamma-
tory effect of the pure drug, optimized microsphere formulation (F7) and commercial
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aceclofenac SR tablet (10). Overnight fasted animals were divided into 4 groups (n = 6)
and treated as follows: group I (control): 2.5 mL of 0.5 % sodium carboxymethylcellulose
(CMC), p.o.; group II: pure aceclofenac (10 mg kg–1) in 0.5 % CMC, p.o.; group III: opti-
mized algino-pectinate microsphere (F7) (10 mg kg–1) in 0.5 % CMC, p.o.; group IV: com-
mercial SR tablet (MKT) (Aristo, India) (10 mg kg–1) in 0.5 % CMC, p.o. After 30 min of
drug administration, rats of all groups were challenged by a subcutaneous injection of
0.05 mL of 1 % solution of carrageenean in saline into the plantar site of the left hind
paw. Paw volumes were measured at different time intervals with a plethysmometer
(INCO, India) prior to carrageenean administration. The percent inhibition of edema for
all time intervals was then calculated.
Statistical analysis
In vitro drug release data was subjected to one-way analysis of variance (one-way
ANOVA). Statistical analysis of the data was performed using the PRISM software
(Graph pad, San Diego, CA, USA). In vivo data (% inhibition) was subjected to one-way
ANOVA followed by Dunnett’s multiple comparison test to find out whether any signi-
ficant difference was present between commercial formulation and the optimized micro-
sphere formulation.
RESULTS AND DISCUSSION
Physicochemical characterization of microspheres
The yield was 93.1 ± 2.8 % (range 88.3 to 95.7 %), particle size of the microspheres
was 0.72 ± 0.07 mm (range 0.61–0.81 mm) and entrapment efficiency was found to be
85.4 ± 1.8 % (range 73.2 to 96.9 %). Table I summarizes the data for all formulation. It
was found that by increasing the polymer concentration, particle size as well as encap-
sulation efficiency of microspheres increased. This may be due to higher polymer concen-
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F1 Sodium alginate (1) 88.3 ± 2.3 73.2 ± 2.1 0.61 ± 0.02
F2 Sodium alginate (2) 90.1 ± 2.4 77.2 ± 1.5 0.67 ± 0.04
F3 Sodium alginate (3) 93.4 ± 3.2 82.5 ± 1.7 0.70 ± 0.05
F4 Sodium alginate (4) 92.2 ± 2.9 84.6 ± 1.6 0.72 ± 0.11
F5 Sodium alginate (1) + pectin (1) 95.5 ± 3.4 86.1 ± 2.9 0.74 ± 0.05
F6 Sodium alginate (1) + pectin (2) 94.5 ± 2.0 89.7 ± 1.5 0.81 ± 0.08
F7 Sodium alginate (1) + pectin (3) 95.7 ± 3.6 93.2 ± 2.2 0.75 ± 0.14
F8 Sodium alginate (1) + pectin (4) 94.7 ± 2.9 96.9 ± 1.1 0.79 ± 0.07
a Mean ± SD, n = 3.
tration, which increases the viscosity of the medium and makes greater availability of
calcium binding sites in polymeric chains. As a result, the degree of cross-linking increa-
sed and larger droplets were formed, entrapping a higher amount of the drug.
Micromeritic properties of microspheres
The angle of repose and Carr’s index of the pure drug were found to be 39.4 ± 1.1°
and 32.6 ± 1.7, which indicate a poor flow property. The angle of repose and Carr’s index
of the prepared microspheres were 17.2 ± 1.3° (14.7 to 19.4°) and 8.5 ± 7.0 (2.7 to 23.4), re-
spectively (Table II). Bulk density of the formulations was found to be 0.40 ± 0.09 g mL–1
(range 0.21 to 0.79 g mL–1) and tapped density was found to be 0.39 ± 0.07 g mL–1 (0.17
to 0.67 g mL–1). The micromeritic study showed that the prepared microspheres had a
good flow property, excellent compressibility, good packability compared to the pure
drug.
Enteric nature of microspheres
Aceclofenac exists in its acidic form which is practically insoluble in the stomach pH
(11). Due to this fact and in an attempt to reduce side effects, the enteric nature of the
microspheres was evaluated in order to find out whether the prepared formulations were
able to restrict the drug release in an acidic environment. Na-alginate microspheres and
algino-pectinate microspheres were able to restrict the drug release in acidic medium,
but some amount of drug was found to be released at stomach pH. It was observed that
a much lower amount of aceclofenac was released in the acidic environment (5.2 %
drug) from Na-alginate microspheres in 0.1 mol L–1 HCl medium, pH 1.2, in 2 hours but
2.2 % in the case of algino-pectinate microspheres. This may be attributed to the fact that
aceclofenac, which is present on the surface of microspheres, immediately comes in con-
tact with the medium (12). Thus these formulations could protect the acid-labile drug
and enzyme from gastric degradation (13).
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PD 0.81 ± 0.09 0.73 ± 0.08 39.4 ± 1.1 32.6 ± 1.7
F1 0.79 ± 0.21 0.67 ± 0.14 19.2 ± 1.1 23.4 ± 1.3
F2 0.64 ± 0.11 0.59 ± 0.07 17.9 ± 0.3 12.1 ± 1.9
F3 0.51 ± 0.09 0.45 ± 0.04 19.4 ± 1.2 10.0 ± 0.8
F4 0.33 ± 0.06 0.49 ± 0.07 16.8 ± 1.4 8.7 ± 1.1
F5 0.23 ±0.03 0.33 ± 0.06 14.7 ± 2.1 4.2 ± 0.8
F6 0.25± 0.07 0.22 ± 0.08 17.8 ± 1.3 3.6 ± 0.3
F7 0.22 ± 0.07 0.19 ± 0.05 16.3 ± 2.1 3.4 ± 0.9
F8 0.21 ± 0.08 0.17 ± 0.08 15.6 ± 1.2 2.7 ± 0.3
PD – pure drug, a Mean ± SD, n = 3.
Scanning electron micrograpy
Scanning electron micrographs (SEM) of the microspheres are shown in Fig. 1. The
SEM results revealed that all the aceclofenac loaded microspheres were discrete and sphe-
rical in shape, with a rough outer surface. The surface of the microspheres was rough
due to the density of the polymer matrix, which in turn justified its sustained release.
Bioadhesive property of microspheres
All the microspheres exhibited good bioadhesive properties, as observed in the in
vitro wash-off test. It was found that both Na-alginate and algino-pectinate microspheres
had less bioadhesion in simulated gastric fluid (pH 1.2) compared to simulated intesti-
nal fluid (pH 6.8). This may be due to the fact that Na-alginate is practically insoluble in
aqueous acidic solution whereas in simulated intestinal fluid its solubility, hydration and
bioadhesivity property were increased due to ionization of the carboxyl acid group and
other functional groups present in the polymer. This increased solubility allowed more
solvent to penetrate the polymeric coat, produce a viscous gel and increase the bioad-
hesion property.
It was also observed that algino-pectinate microspheres had a better bioadhesive
property (Fig. 2) than alginate microspheres, because a combination of both polymers in-
creases the viscosity of the matrix, which helps in increasing adhesion to intestinal mu-
cosa. Adhesion of the microspheres to the intestine mucosa for a prolonged period is sug-
gested where they release the drug in a sustained manner.
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Fig. 1. Scanning electron pho-
tomicrographs of the algino-
-pectinate microspheres (F7):
a) 50 X, b) 100 X, c) 200 X, d)
750 X.
FTIR
FTIR spectra are shown in Fig. 3. Pure aceclofenac showed different peaks at 3319.2,
3278.9, 1771.7, 1716.8, 1589.4, 1508.1, 1344.3, 1280.6, 1149.4 and 1055.8 cm–1. Among them
some major peaks are 3319.2 for stretching vibration of OH of COOH group, 3278.9 for
stretching vibration of NH group, 1716.8 for stretching vibration of C=O attached to the
methylene group and ether, 1280.6 for C-N stretching vibration of secondary aromatic
amine, 1149.4 for aliphatic ether (asymmetric C-O-C stretching), 1055.8 for OH bending
vibration. In the optimized formulation (F7), all the above mentioned peaks were intact
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Fig. 2. Bioadhesion behavior of algino-pec-
tinate optimized formulation (F7) (mean ±
SD, n = 3) in 0.1 mol L–1 HCl (pH 1.2) and
in phosphate buffer (pH 6.8).













Fig. 3. FT-IR spectra of pure
aceclofenac (I), Na-alginate
(II), pectin (III), optimized for-
mulation F7 (IV).
and no considerable changes in the IR peaks were observed. FTIR spectra thus indicate
the stable nature of aceclofenac in the prepared formulations.
In vitro drug release study
The effect of the polymer level on the release of AC from the microspheres was
studied (F1-F8). Formulations F1, F2, F3 and F4 were able to sustain the drug release for
4, 5, 7 and 8 hours, respectively, whereas algino-pectinate microspheres (F5 to F7) were
able to sustain the drug release for 10 to 12 hours (Fig. 4). On increasing the quantity of
pectin up to 4 % (m/V), the release of the drug was too slow and only 68.3 % of the drug
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Fig. 4. Cumulative drug released vs. time
(mean ± SD, n = 3) from pure drug (PD)
to F8.













F1 0.924 6.342 1.000 0.918 0.80
F2 0.934 5.787 0.999 0.908 1.18
F3 0.944 4.985 0.996 0.873 1.40
F4 0.926 4.890 0.996 0.759 2.05
F5 0.895 6.448 0.956 0.527 4.65
F6 0.906 5.479 0.930 0.657 5.87
F7 0.891 4.063 0.955 0.733 6.99
F8 0.736 2.302 0.963 0.689 9.87
was released after 12 hours. Formulations containing Na-alginate alone (F1 to F4) under-
went erosion before complete swelling could take place, resulting in faster drug release.
It was also observed that at acidic pH drug release was extremely slow and increased in
phosphate buffer. This is because at acidic pH, alginate microspheres shrink due to the
tightening of gel meshwork, whereas at pH 6.8 alginate errodes and releases the con-
tents in a sustained manner (14). Algino-pectinate microspheres (F5 to F8) were more ef-
ficient in sustaining the drug release compared to alginate microspheres (F1-F4) because
pectin could form a rigid coat with calcium ions (15), thus forming a calcium-pectinate
gel matrix. Free carboxyl groups in the HM pectin molecule are distributed block-wise;
therefore the gelation of this pectin is possible because of the »egg-box« structure, result-
ing from chelation of calcium ions in electronegative cavities formed by the carboxyl res-
idues and hydroxyl groups (16). One way analysis of variance suggested that a signifi-
cant difference at p < 0.05 was present among all the formulations F1 to F8 with respect
to in vitro drug release. Among all the formulations, F7 showed the best dissolution pro-
file (more than 90 % drug was released in 12 hours), so it was selected for the in vivo
study.
The coefficient of determination (R2) was used as an indicator of the best fitting for
each of the models considered (Table III). Kinetic data of all the formulations reached a
higher coefficient of determination (R2 = 0.963–1.000) with the Korsmeyer-Peppas model
whereas the release exponent value (n) ranged from 0.527 to 0.918. The release exponent
in the Korsmeyer-Peppas model suggested that the mechanism that led to the release of
aceclofenac was an anomalous non-Fickian diffusion mechanism pointing to the conclu-
sion that a combined release mechanism of drug diffusion and sphere erosion might be
appropriate.
Preliminary anti-inflammatory activity study
Inhibition of rat paw edema at each time point was calculated (Table IV). Pure drug
exhibited comparatively rapid anti-inflammatory activity. Inhibition values of the pure
drug were higher than those of test and commercial formulations. In the case of F7 and
commercial SR tablet the inhibition effect was slowly attained. However, at the end of
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1 29.0 ± 1.2 10.3 ± 2.1c 45.6 ± 3.2c
2 49.0 ± 2.1 30.6 ± 0.9c 61.7 ± 2.5c
3 69.6 ± 2.1 51.8 ± 3.2c 73.9 ± 0.7c
4 73.6 ± 2.1 67.7 ± 2.7c 80.6 ± 2.6c
5 72.3 ± 1.0 76.3 ± 1.9c 82.3 ± 0.8c
a Dose: 10 mg kg–1.
b Mean ± SD, n = 6. PD – pure aceclofenac, F7 – optimized formulation, MKT – commercial aceclofenac
SR tablet (100 mg).
c Significant difference compared to PD (p < 0.05).
experiment, both exhibited highest anti-inflammatory activity at a dose level of 10 mg
kg–1 (76.3 ± 1.9 % in case of formulation F7 and 82.3 ± 0.8 % inhibition in case of com-
mercial SR tablet). Both F7 and commercial formulations restricted drug release in the
stomach and gradually increased the release when they entered the intestine. Dunnett’s
test suggested a significant difference for percent inhibition when the optimized formu-
lation F7 was compared with the pure drug but no such event was observed when com-
pared with the commercial aceclofenac SR tablet. The results indicate that the prepared
microspheres F7 and commercial SR tablet produce sustained action of aceclofenac.
CONCLUSIONS
In conclusion, the algino-pectinate formulations exhibit promising properties of a
controlled release form for aceclofenac. Theoretical models of the drug release indicated
that drug release from the microspheres was triggered by matrix disintegration followed
by swelling and relaxation of the polymer chain. In vivo data showed a significant differ-
ence for percent inhibition when the optimized formulation was compared with the pure
drug.
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S A @ E T A K
Priprava, in vitro i in vivo evaluacija bioadhezivnih mikrosfera s algino-pektinom:
Ispitivanje utjecaja polimera pomo}u multiple poredbene analize
SANTANU CHAKRABORTY, MADHUSMRUTI KHANDAI, ANURADHA SHARMA, NAZIA KHANAM,
CH. NIRANJAN PATRA, SUBAS CHANDRA DINDA i KALYAN KUMAR SEN
U radu je opisana priprava algino-pektinskih bioadhezivnih mikrosfera protuupal-
nog lijeka aceklofenaka metodom ionotropnog geliranja. In vitro je ispitivana mogu}nost
postupnog osloba|anja ljekovite tvari iz mikrosfera te mogu}nost upotrebe mikrosfera
kao gastroprotektivnog sustava za isporuku aceklofenaka in vivo. Ispitivan je utjecaj kon-
centracije polimera i omjera polimera i lijeka na svojstva mikrosfera. Mikrosfere su bile
bioahezivne i sadr`avale su veliki udio lijeka. Osloba|anje aceklofenaka iz alginatnih
mikrosfera bilo je br`e, a iz mikrosfera s algino-pektinom usporeno. Dunnetova multipla
analiza ukazuje na zna~ajnu razliku u postotku inhibicije edema {ape kada se usporede
optimizirana formulacija i ~ista ljekovita tvar. Mo`e se zaklju~iti da su bioadhezivne mi-
krosfere s algino-pektinom povoljne za usporeno osloba|anje aceklofenaka te da pru-
`aju umjerenu za{titu sluznice `eluca.
Klju~ne rije~i: mikrosfere s algino-pektinom, aceklofenak, bioadhezija, ionotropno geliranje, ispiti-
vanje in vivo
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